Katherine D. Westmoreland

Katherine D. Westmoreland

Auto-generated profile, based on publicly available information

Katherine D. Westmoreland

UNC Project-Malawi, Lilongwe, Malawi

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Pediatric Neurology
Verified
Journal Article
Closed access
DBDavid R. Bearden
David R. Bearden
BMBaphaleng Monokwane
Baphaleng Monokwane
EKEsha Khurana
Esha Khurana
JBJames Baier
James Baier
EBEsther Baranov
Esther Baranov
ASAndrew P. Steenhoff
Andrew P. Steenhoff

17 July 2018 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
KWKatherine Westmoreland
Katherine Westmoreland
BRBryce B. Reeve
Bryce B. Reeve
AAAmy Amuquandoh
Amy Amuquandoh
TGToon van der Gronde
Toon van der Gronde
OMOlivia Manthalu
Olivia Manthalu
SGSatish Gopal
Satish Gopal

17 October 2018 in Palliative and Supportive Care
Verified
Journal Article
Open access
PDF file
KWKatherine D. Westmoreland
Katherine D. Westmoreland
FBFrancis M. Banda
Francis M. Banda
ASAndrew P. Steenhoff
Andrew P. Steenhoff
ELElizabeth D. Lowenthal
Elizabeth D. Lowenthal
EIErik Isaksson
Erik Isaksson
BFBernhard A. Fassl
Bernhard A. Fassl
Objective: The purpose of this study was to demonstrate effectiveness of an educational training workshop using role-playing to teach medical students in Botswana to deliver bad news.Method: A 3-hour small group workshop for University of Botswana medical students rotating at the Princess Marina Hospital in Gaborone was developed. The curriculum included an overview of communication basics and introduction of the validated (SPIKES) protocol for breaking bad news. Education strategies included didactic lecture, handouts, role-playing cases, and open forum discussion. Pre- and posttraining surveys assessed prior exposure and approach to breaking bad news using multiple-choice questions and perception of skill about breaking bad news using a 5-point Likert scale. An objective structured clinical examination (OSCE) with a standardized breaking bad news skills assessment was conducted; scores compared two medical student classes before and after the workshop was implemented.Result: Forty-two medical students attended the workshop and 83% (35/42) completed the survey. Medical students reported exposure to delivering bad news on average 6.9 (SD= 13.7) times monthly, with 71% (25/35) having delivered bad news themselves without supervision. Self-perceived skill and confidence increased from 23% (8/35) to 86% (30/35) of those who reported feeling “good” or “very good” with their ability to break bad news after the workshop. Feedback after the workshop demonstrated that 100% found the SPIKES approach helpful and planned to use it in clinical practice, found role-playing helpful, and requested more sessions. Competency for delivering bad news increased from a mean score of 14/25 (56%,SD= 3.3) at baseline to 18/25 (72%,SD= 3.6) after the workshop (p= 0.0002).Significance of results: This workshop was effective in increasing medical student skill and confidence in delivering bad news. Standardized role-playing communication workshops integrated into medical school curricula could be a low-cost, effective, and easily implementable strategy to improve communication skills of doctors.

22 February 2019 in Blood Advances
Verified
Journal Article
Open access
PDF file
MPMatthew Painschab
Matthew Painschab
KWKate D. Westmoreland
Kate D. Westmoreland
EKEdwards Kasonkanji
Edwards Kasonkanji
TZTakondwa Zuze
Takondwa Zuze
BKBongani Kaimila
Bongani Kaimila
SGSatish Gopal
Satish Gopal
Burkitt lymphoma (BL) is common in sub-Saharan Africa (SSA). In high-income countries, BL is highly curable with chemotherapy. However, there are few prospective studies from SSA describing nonpediatric BL and no regional standard of care. Thirty-five participants age 15 years or older with newly diagnosed BL were enrolled in Malawi from 2013 to 2018. Chemotherapy was administered according to institutional guidelines, with concurrent antiretroviral therapy if HIV infected. Median age was 21 years (range, 15-61) and 15 participants (43%) were HIV infected. Twenty-seven participants (77%) had stage III to IV disease, and 19 (54%) had Eastern Cooperative Oncology Group performance status >1. Among HIV-infected participants, median CD4 count was 130 (range, 29-605) and 10 (67%) had suppressed HIV viral load. Four participants (11%) died before receiving chemotherapy. First-line chemotherapy consisted of: cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) (n = 22 [71%]); infusional etoposide, prednisolone, vincristine, cyclophosphamide, and doxorubicin (n = 4 [13%]); high-dose methotrexate-based chemotherapy (n = 4 [13%]); and rituximab plus CHOP (n = 1 [3%]). Among 28 evaluable participants, 14 (50%) achieved a complete response. Median overall survival (OS) was 7 months; 1-year OS was 40% (95% confidence interval [CI], 24%-56%). Sixteen (73%) of 22 deaths were a result of disease progression. Compared with CHOP, more intensive chemotherapy was associated with decreased mortality (hazard ratio, 0.24; 95% CI, 0.05-1.02; P = .05). This is among the best characterized prospective cohorts of nonpediatric BL in SSA. Most deaths resulted from progressive BL. Patients who received more intensive therapy seemed to have better outcomes. Defining optimal approaches is an urgent priority in SSA.

9 August 2019 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
TMTisungane Mvalo
Tisungane Mvalo
HTHillary M. Topazian
Hillary M. Topazian
PKPortia Kamthunzi
Portia Kamthunzi
JCJane S. Chen
Jane S. Chen
IKIsobel Kambalame
Isobel Kambalame
KWKate D. Westmoreland
Kate D. Westmoreland

2 August 2021 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
GEGrace K. Ellis
Grace K. Ellis
HCHutton Chapman
Hutton Chapman
AMAgness Manda
Agness Manda
ASAnde Salima
Ande Salima
SISalama Itimu
Salama Itimu
KWKatherine D. Westmoreland
Katherine D. Westmoreland